JScreen, a national non-profit public health initiative based out of Emory University School of Medicine, announces its support of Men’s Health Month this June. JScreen, which is dedicated to preventing genetic diseases and hereditary cancer, urges men everywhere to use this time of increased awareness to take control of their health. With Father’s Day and Men’s Health Month both falling in June, JScreen cannot overemphasize the importance of genetic testing to protect yourself and your family. JScreen has been offering reproductive genetic testing to help couples have healthy babies since 2013. In addition, JScreen now offers a new CancerGEN, test that assesses more than 60 cancer susceptibility genes associated with hereditary risks for prostate, colorectal, skin, and many other types of cancer. The robust cancer panel includes genes that are actionable, meaning steps can be taken to help prevent cancer if a person tests positive. This June, JScreen is working to ensure healthy futures for men and their families across the U.S.

If the pandemic has taught us one thing, it is the importance of quality healthcare. It is paramount that we stay on top of our health and take the steps that we can in order to protect ourselves. Statistics show that at least a third of all men will develop cancer during their lifetime, and that about 10% of cancer is related to genetic causes. One of the first steps to preventing cancer is knowing your hereditary risk.

“To prevent cancer on a wide scale, accessible genetic testing is key,” says Jane Lowe Meisel, MD, Associate Professor of Hematology and Medical Oncology at Emory University School of Medicine, and medical director for JScreen’s cancer program. “Cancer genetic testing makes prevention and early detection possible.”

JScreen launched in 2013 with the goal of giving people the necessary tools to know and understand their genetic risks. By providing convenient, at-home access to cutting-edge genetic testing technology, patient education, and genetic counseling services, JScreen strives to minimize the incidence of preventable genetic diseases and ensure a bright and healthy future.

Getting tested through JScreen is easy. All you have to do to receive your simple at-home test is sign up online at JScreen.org. You’ll then provide a saliva sample and use the pre-paid postage to mail it in. JScreen’s tests use state-of-the-art genetic sequencing technology to ensure highly accurate results. A unique feature of JScreen’s process is that it provides access to licensed genetic counselors who provide consults via phone or secure video conferencing to ensure that people understand their results.

As a not-for-profit at-home education and genetic screening program, one of JScreen’s goals is to make testing affordable. With insurance, JScreen’s reproductive genetic test, ReproGEN, costs $149, and the CancerGEN test costs just $199.

The proof of JScreen’s passion for saving lives is in the incredible stories they hear and the people who can now take action to avoid genetic diseases in their children or a future cancer diagnosis in themselves. As the team at JScreen likes to say: “we are a small team with a huge footprint.”

“With so many stressors and uncertainties in the world, your health shouldn’t have to be one of them,” says Hillary Regelman, Director of National Outreach and Marketing at JScreen. “We want to not only tell people about their risks, but also help them understand what they mean, so that they can work with their healthcare providers to take the best and most effective steps possible toward a long and healthy future for themselves and their families.”

About The Publishers
JScreen
JScreen
JScreen is a national non-profit public health initiative dedicated to preventing genetic diseases and cancers common in Jewish and other populations. Headquartered in Atlanta at Emory University School of Medicine, the JScreen initiative provides convenient at-home access to cutting-edge genetic testing technology, patient education and genetic counseling services. JScreen believes the combination of education, access to premier genetic screening technologies and personalized, confidential support are the keys to preventing devastating diseases. Please visit JScreen.org for more information.
Releases published on the JNS Wire are communicated and paid for by third parties. Jewish News Syndicate, and any of its distribution partners, take zero responsibility for the accuracy of any content published in any press release. All the statements, opinions, figures in text or multimedia including photos or videos included in each release are presented solely by the sponsoring organization, and in no way reflect the views or recommendation of Jewish News Syndicate or any of its partners. If you believe any of the content in a release published on JNS Wire is offensive or abusive, please report a release.